Atria Investments Inc decreased its position in Kimberly-Clark Co. (NYSE:KMB - Free Report) by 43.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,335 shares of the company's stock after selling 2,577 shares during the period. Atria Investments Inc's holdings in Kimberly-Clark were worth $437,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Assetmark Inc. lifted its stake in Kimberly-Clark by 5.2% in the fourth quarter. Assetmark Inc. now owns 15,606 shares of the company's stock worth $2,045,000 after acquiring an additional 773 shares during the period. SWS Partners lifted its position in shares of Kimberly-Clark by 3.1% during the fourth quarter. SWS Partners now owns 10,741 shares of the company's stock valued at $1,420,000 after buying an additional 319 shares during the last quarter. Exencial Wealth Advisors LLC boosted its holdings in shares of Kimberly-Clark by 8.9% in the 4th quarter. Exencial Wealth Advisors LLC now owns 1,614 shares of the company's stock valued at $211,000 after buying an additional 132 shares in the last quarter. Commerzbank Aktiengesellschaft FI grew its position in shares of Kimberly-Clark by 8.3% in the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 11,971 shares of the company's stock worth $1,564,000 after buying an additional 916 shares during the last quarter. Finally, Patten Group Inc. increased its position in shares of Kimberly-Clark by 1.3% during the fourth quarter. Patten Group Inc. now owns 63,254 shares of the company's stock worth $8,289,000 after purchasing an additional 813 shares in the last quarter. Institutional investors own 76.29% of the company's stock.
Analyst Upgrades and Downgrades
KMB has been the topic of several recent research reports. UBS Group upped their price objective on shares of Kimberly-Clark from $132.00 to $134.00 and gave the company a "neutral" rating in a report on Wednesday, January 29th. Barclays reduced their price objective on shares of Kimberly-Clark from $144.00 to $132.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. dropped their price target on Kimberly-Clark from $140.00 to $124.00 and set an "underweight" rating for the company in a research report on Thursday, January 16th. Piper Sandler restated an "overweight" rating and issued a $158.00 price target (down from $161.00) on shares of Kimberly-Clark in a research report on Wednesday, January 29th. Finally, Wells Fargo & Company reduced their price target on shares of Kimberly-Clark from $140.00 to $130.00 and set an "equal weight" rating on the stock in a research report on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Kimberly-Clark presently has a consensus rating of "Hold" and a consensus price target of $143.64.
Get Our Latest Report on KMB
Insider Buying and Selling
In related news, VP Andrew Drexler sold 10,838 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $141.00, for a total value of $1,528,158.00. Following the completion of the sale, the vice president now owns 7,720 shares in the company, valued at approximately $1,088,520. This trade represents a 58.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.62% of the company's stock.
Kimberly-Clark Stock Performance
Shares of NYSE:KMB traded up $0.22 on Wednesday, hitting $139.75. The company's stock had a trading volume of 999,676 shares, compared to its average volume of 2,016,481. The stock's 50-day moving average is $134.05 and its two-hundred day moving average is $136.34. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The company has a market capitalization of $46.35 billion, a price-to-earnings ratio of 18.51, a price-to-earnings-growth ratio of 4.46 and a beta of 0.36. Kimberly-Clark Co. has a 12 month low of $123.02 and a 12 month high of $150.45.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The company reported $1.50 earnings per share for the quarter, hitting the consensus estimate of $1.50. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. On average, equities research analysts forecast that Kimberly-Clark Co. will post 7.5 EPS for the current year.
Kimberly-Clark Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 2nd. Shareholders of record on Friday, March 7th will be issued a dividend of $1.26 per share. This is a positive change from Kimberly-Clark's previous quarterly dividend of $1.22. This represents a $5.04 annualized dividend and a yield of 3.61%. The ex-dividend date is Friday, March 7th. Kimberly-Clark's dividend payout ratio (DPR) is 66.75%.
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report